The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (396794)
ARTG Name
Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag
Product name
T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus
ARTG Date
Registration Type
Biological
Therapeutic good type
Biological
Sponsor
Ingredients
brexucabtagene autoleucel
Licence category
INC
Licence status
A
Licence class
Class 4
Summary
Product Information
Consumer Medicine Information